- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/06 - Antiglaucoma agents or miotics
Patent holdings for IPC class A61P 27/06
Total number of patents in this class: 1714
10-year publication summary
|
63
|
97
|
104
|
106
|
146
|
132
|
104
|
128
|
93
|
68
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2162 |
105 |
| Santen Pharmaceutical Co., Ltd. | 595 |
75 |
| Nicox S.A. | 144 |
27 |
| Kowa Company, Ltd. | 1233 |
21 |
| Senju Pharmaceutical Co., Ltd. | 224 |
21 |
| The Regents of the University of California | 20790 |
19 |
| Regeneron Pharmaceuticals, Inc. | 4741 |
18 |
| Alcon, Inc. | 5883 |
13 |
| Ono Pharmaceutical Co., Ltd. | 422 |
13 |
| Daiichi Sankyo Company, Limited | 1890 |
12 |
| Alcon Research, Ltd. | 333 |
10 |
| Bausch & Lomb Incorporated | 1063 |
10 |
| Eye Therapies LLC | 43 |
10 |
| Takeda Pharmaceutical Company Limited | 2713 |
9 |
| The Regents of the University of Colorado, a body corporate | 2812 |
9 |
| Rohto Pharmaceutical Co., Ltd. | 414 |
9 |
| Dainippon Sumitomo Pharma Co., Ltd. | 166 |
8 |
| Fundacio Hospital Universitari Vall D'hebron - Institut de Recerca | 152 |
8 |
| Massachusetts Eye and Ear Infirmary | 403 |
8 |
| Novaliq GmbH | 175 |
8 |
| Other owners | 1301 |